BZAM Ltd.
BZAMFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$2708
P/E Ratio—
52W High$0.001
52W Low$0.00001
BZAM Ltd. (BZAMF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BZAMF · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 28, 2023EPS Actual
-$0.07
Revenue
$0.02B
Est. $0.02B · +13.9%
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 28, 2023
After Market Close
▲ Beat Revenue
BZAMF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2024 | Dec 2, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Aug 14, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | Jun 28, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 19, 2024 | — | — | — | — | $0.02B | — |
| — Q4 FY2023 | Nov 28, 2023 | — | -$0.07 | — | $0.02B | $0.02B | +13.9% |
| — Q3 FY2023 | Aug 24, 2023 | — | -$0.05 | — | $0.01B | $0.02B | -18.3% |
| — Q2 FY2023 | May 30, 2023 | — | -$0.09 | — | $0.02B | $0.02B | +0.8% |
| — Q2 FY2023 | Apr 28, 2023 | — | -$0.06 | — | — | $0.01B | — |
Q4 FY2024
Dec 2, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 19, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 28, 2023
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q3 FY2023
Aug 24, 2023
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2023
May 30, 2023
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2023
Apr 28, 2023
EPS Actual
-$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2029 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Nov 28, 2023 | — | $0.01 | $0.01 | -0.97% |
| — Q3 FY2023 | Aug 24, 2023 | — | $0.01 | $0.01 | -14.04% |
| — Q2 FY2023 | May 30, 2023 | — | $0.02 | $0.02 | +4.55% |
| — Q2 FY2023 | Apr 28, 2023 | — | $0.02 | $0.02 | +5.36% |
| — Q4 FY2022 | Nov 23, 2022 | — | $0.05 | $0.05 | -5.02% |
| — Q3 FY2022 | Aug 29, 2022 | — | $0.07 | $0.07 | +0.00% |
| — Q2 FY2022 | May 25, 2022 | — | $0.08 | $0.08 | +2.56% |
Q4 FY2023-0.97%
Report Date
Nov 28, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2023-14.04%
Report Date
Aug 24, 2023
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2023+4.55%
Report Date
May 30, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2023+5.36%
Report Date
Apr 28, 2023
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2022-5.02%
Report Date
Nov 23, 2022
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q3 FY2022+0.00%
Report Date
Aug 29, 2022
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q2 FY2022+2.56%
Report Date
May 25, 2022
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Beat Rate0 / 7 quarters
Largest Move-14.04% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BZAMF ends December
BZAM Ltd. (BZAMF) most recently reported earnings on November 28, 2023 for Q4 FY2023, posting EPS of $-0.07 (in line with the analyst consensus of —). The next BZAMF earnings date is expected around September 1, 2026.
Each quarter, investors track BZAMF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BZAMF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BZAMF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BZAMF earnings · 4 questionsBZAM Ltd.'s next earnings report is expected around September 1, 2026. BZAMF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BZAMF historically reports after market close (AMC).
BZAMF earnings datewhen is BZAMF earningsBZAMF next earnings datewhen does BZAMF report earningsBZAMF earnings calendar
▸ Source: FMP · BZAM Ltd. SEC filings · US GAAP · BZAM Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026